Claims
- 1. A compound of the formula: ##STR127## where R.sub.1 is selected from the group consisting of hydrogen, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, benzyl and phenethyl; A is --CH.dbd.CH-- or ##STR128## wherein R.sub.2 or R.sub.3 may be the same or different and are selected from the group consisting of hydrogen and C.sub.1-4 alkyl; R.sub.6 and R.sub.7 may be the same or different and are selected from the group consisting of hydrogen, C.sub.1-4 alkyl, benzyl, phenethyl and together with the nitrogen atom, a heterocyclic group selected from the group consisting of a piperidino, morpholino, piperazino or thiazolino group; and m and n each are zero or a positive integer with m+n being no more than 11.
- 2. A compound according to claim 1 wherein A is ##STR129##
- 3. A pharmaceutical composition for inhibiting platelet aggregation which comprises a compound as claimed in claim 1 and a pharmaceutically acceptable carrier.
- 4. A method for inhibiting platelet aggregation in the blood of a subject which comprises administering to the subject a pharmaceutical composition containing the compound of claim 1 and a pharmaceutically acceptable carrier in a dosage equivalent to about 0.1 mg. to about 100 mg. of said compound per day per kg. of weight of the subject.
Parent Case Info
This is a division of Application Ser. No. 806,926 filed June 15, 1977 now U.S. Pat. No. 4,216,220 which is a division of application Ser. No. 588,475, filed June 19, 1975 and now U.S. Pat. No. 4,070,470.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
3860609 |
Lundt |
Jan 1975 |
|
4026897 |
Nakagawa et al. |
May 1977 |
|
4070470 |
Nakagawa et al. |
Jan 1978 |
|
4147869 |
Nakagawa et al. |
Apr 1979 |
|
Divisions (2)
|
Number |
Date |
Country |
Parent |
806926 |
Jun 1977 |
|
Parent |
588475 |
Jun 1975 |
|